A CE mark on a medical device means it meets the safety and performance standards required to be sold in the European Union. The letters “CE” stand for “Conformité Européenne” (French for “European Conformity”), and the marking acts as a manufacturer’s declaration that the product complies with all applicable EU regulations. For medical devices specifically, the governing law is the Medical Device Regulation (EU) 2017/745, commonly called the MDR.
Unlike a stamp of approval from a single government agency, the CE marking system relies on a combination of manufacturer self-assessment and independent review. The level of scrutiny depends on how risky the device is. A simple bandage faces far fewer hurdles than an implantable heart valve.
How Medical Devices Are Classified by Risk
The EU sorts medical devices into four risk classes, and the class determines how much independent oversight a manufacturer needs before it can apply the CE mark.
- Class I (low risk): Non-invasive, everyday devices like tongue depressors or reusable surgical instruments. Standard Class I devices can be self-certified by the manufacturer without outside review. However, if the device is sold sterile, has a measuring function, or is a reusable surgical instrument, an independent review body must verify those specific aspects.
- Class IIa (low to medium risk): Devices typically placed inside the body for short periods, between 60 minutes and 30 days. Examples include hearing aids and urinary catheters. These require independent assessment.
- Class IIb (medium to high risk): More complex devices often implanted for 30 days or longer, such as ventilators or certain orthopedic implants. The review process is similar to Class IIa but includes additional scrutiny of the technical documentation for implantable devices.
- Class III (high risk): Devices that pose the greatest potential for harm, like pacemakers, drug-eluting stents, and hip replacements. These face the most rigorous assessment pathway.
The Role of Notified Bodies
For any device above standard Class I, the manufacturer cannot simply self-certify. It must involve a “notified body,” an independent organization designated by an EU member state to evaluate whether a device conforms to the regulations. Notified bodies are not government agencies. They are accredited private organizations authorized to carry out conformity assessments when the law requires third-party review.
The European Commission maintains a public database called NANDO that lists all designated notified bodies, searchable by the type of regulation they cover. Manufacturers choose a notified body from this list. When a notified body is involved in the certification, its four-digit identification number appears directly next to the CE marking on the product.
Steps to Getting a CE Mark
There is no central EU agency that grants CE marks. Instead, the manufacturer takes responsibility for demonstrating compliance through a structured process:
First, the manufacturer identifies every EU requirement that applies to the device. Then it determines whether the device can be self-assessed or needs a notified body, based on its risk class. The manufacturer compiles a technical file containing detailed evidence that the device meets those requirements. Finally, the manufacturer drafts and signs an EU Declaration of Conformity, a legal document stating the product complies with all applicable rules.
Both the Declaration of Conformity and the supporting technical documentation must be kept up to date and retained for at least 10 years after the product is placed on the market. If a national authority requests these documents, the manufacturer must be able to produce them.
What Goes Into the Technical File
The technical file is the backbone of CE marking. It’s an extensive dossier that proves the device is safe and performs as claimed. Under the MDR’s Annex II, this file must include:
- Device description: The product’s trade name, intended purpose, intended users, patient population, medical conditions it addresses, indications, contraindications, and warnings.
- Design and function: A clear explanation of how the device works, its key components (including software), raw materials, and qualitative and quantitative composition. Diagrams, photographs, and labeled drawings are expected.
- Risk classification justification: Why the device falls into its particular risk class under the EU’s classification rules.
- History of similar devices: An overview of any previous generations of the device the manufacturer has produced, plus identified similar devices already on the EU or international market.
- Labeling and instructions: All labels and instructions for use, translated into the languages of the member states where the device will be sold.
- Clinical evaluation: Evidence demonstrating that the device is safe and performs as intended when used on patients.
For higher-risk devices, the notified body reviews this file in detail. For Class IIb implantable devices, every product’s technical documentation gets assessed individually, with limited exceptions.
Physical Requirements for the Mark Itself
The CE marking consists of the initials “CE” with both letters at the same vertical height. Its minimum size is 5 millimeters, and if it’s scaled up, the proportions must be preserved. The mark can appear in different colors or styles (solid or hollow) as long as it remains clearly visible and legible. It should be affixed directly on the product whenever possible. If that’s not practical, it can go on the packaging or accompanying documents.
How CE Marking Differs From FDA Approval
The CE system and the U.S. FDA take fundamentally different approaches. The CE marking process focuses primarily on safety and on verifying that the device does what the manufacturer claims it does. The FDA goes further by also evaluating efficacy, meaning not just whether a device works as described, but how well it works and what clinical value it provides.
The structural difference is equally important. The CE system relies more heavily on self-regulation and conformity assessment through notified bodies. The FDA functions as a centralized regulatory authority that directly reviews and either clears or approves devices. In practice, this has historically meant that some devices reach the European market before they become available in the United States.
Transition Deadlines Under the New MDR
The MDR replaced the older Medical Devices Directive (MDD), and many manufacturers are still transitioning their existing products to the new framework. Extended deadlines now apply based on device class. Class III and Class IIb implantable devices must fully comply with the MDR by December 31, 2027. All other devices, including Class IIa, lower-risk Class IIb, and Class I devices requiring notified body involvement, have until December 31, 2028.
These extensions were introduced because the transition proved far more complex than originally anticipated, partly due to a shortage of notified bodies designated under the new regulation.
CE Marking and the UK Market
After Brexit, the UK created its own marking system called UKCA (UK Conformity Assessed). However, the government has continued to accept CE-marked medical devices on the Great Britain market during a transition period. General medical devices that carry a valid CE mark under the older EU directives (MDD or AIMDD) can be placed on the Great Britain market until the earlier of the certificate’s expiry date or June 30, 2028. After that, manufacturers selling into Great Britain will need to meet the UK’s own regulatory requirements.